CIK 0001618835
- Non-accelerated filer
- Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208527075
- Phone
- +1 858-550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-09-18 | Kemmerer Christopher VP, Pharma Dev & Manufacturing | Option exercise | +1,000 | $1.34 | $1K | 11,848 |
| 2015-09-18 | Kemmerer Christopher VP, Pharma Dev & Manufacturing | Sale | −1,000 | $12.20 | $12K | 10,848 |
| 2015-09-18 | Kemmerer Christopher VP, Pharma Dev & Manufacturing | Option exercise · Stock Option (Right to Buy) | −1,000 | 50,182 | ||
| 2015-08-07 | Kemmerer Christopher VP, Pharma Dev & Manufacturing | Option exercise | +1,000 | $1.34 | $1K | 11,848 |
| 2015-08-07 | Kemmerer Christopher VP, Pharma Dev & Manufacturing | Option exercise · Stock Option (Right to Buy) | −1,000 | 51,182 | ||
| 2015-08-07 | Kemmerer Christopher VP, Pharma Dev & Manufacturing | Option exercise | +1,000 | $1.22 | $1K | 11,848 |
| 2015-08-07 | Kemmerer Christopher VP, Pharma Dev & Manufacturing | Sale | −1,000 | $12.88 | $13K | 10,848 |
| 2015-08-07 | Kemmerer Christopher VP, Pharma Dev & Manufacturing | Option exercise · Stock Option (Right to Buy) | −1,000 | 1,710 | ||
| 2015-06-12 | Kemmerer Christopher VP, Pharma Dev & Manufacturing | Option exercise | +10,848 | $1.22 | $13K | 10,848 |
| 2015-06-12 | Kemmerer Christopher VP, Pharma Dev & Manufacturing | Option exercise · Common Stock (Right to Buy) | −10,848 | 0 | ||
| 2015-02-10 | Kemmerer Christopher VP, Pharma Dev & Manufacturing | Grant or award · Stock Option (Right to Buy) | +42,350 | 42,350 |
Page 1 of 1 · 11 trades